Scancell
UKRI awards funding for COVID-19 trialScancell
Transformational £15m capital raise closesScancell
Material fund raise means clinical progress in sightScancell
COVID 2nd generation vaccine opportunity is all upsideScancell
Reasons to be cheerfulScancell
US IND for SCIB1 gives Phase II study the green lightScancell
Interim results show encouraging progressScancell
Third collaboration for AvidiMab platformScancell
Second collaboration for AvidiMab platformScancell
A sweet source of financing